Role of rosiglitazone in lipopolysaccharide-induced peritonitis: A rat peritoneal dialysis model

被引:7
|
作者
Song, Sang Heon [1 ,2 ]
Kwak, Ihm Soo [1 ,2 ]
Yang, Byeong Yun [1 ,2 ]
Lee, Dong Won [1 ,2 ]
Lee, Soo Bong [1 ,2 ]
Lee, Min Young [2 ]
机构
[1] Pusan Natl Univ Hosp, Dept Internal Med, Pusan 602739, South Korea
[2] Pusan Natl Univ Hosp, Med Res Inst, Pusan 602739, South Korea
关键词
peritoneal dialysis; peritonitis; peroxisome proliferator-activated receptor-gamma; ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; MESOTHELIAL CELLS; DOWN-REGULATION; EXPRESSION; ALPHA; DIFFERENTIATION; AGONIST; DISEASE; INJURY;
D O I
10.1111/j.1440-1797.2008.01037.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim: The aim of this study was to demonstrate the efficacy of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist, rosiglitazone, in the amelioration or prevention of inflammation including peritoneal fibrosis secondary to the peritonitis in a peritoneal dialysis (PD) model of non-uraemic rats. Methods: Thirty male Sprague-Dawley rats were assigned to six groups according to treatment. A 90 min peritoneal equilibrium test, dialysate cellular components, peritoneal thickness and cellularity were assessed on day 21. Additionally, immunohistochemical stains of peritoneal membrane, such as PPAR-gamma, vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-beta 1, collagen-1 and monocyte chemoattractant protein-1 were performed Results: The dialysate neutrophil count and peritoneal thickness in the high-dose rosiglitazone group was significantly decreased compared to the lipopolysaccharide (LPS)-only group. The peritoneal membrane from the LPS-only group showed marked cellular proliferation in the area of the submesothelial compact zone compared with the PD-only group, the rosiglitazone-only group, and the high-dose rosiglitazone group. The 90 min peritoneal equilibrium test (PET) results showed no statistical difference among the six groups excluding dialysate-to-plasma urea ratio. The number of PPAR-gamma expressing cells and the expression of TGF-beta 1 were decreased in the high-dose rosiglitazone group compared to the LPS-only group. There were no differences in the expression of VEGF and collagen-1 among the six groups. Interestingly, the number of PPAR-gamma-positive cells was correlated with expression of VEGF, TGF-beta 1, collagen-1 and monocyte chemoattractant protein-1 irrespective of the study group. Conclusion: The results of this study showed that rosiglitazone ameliorated peritoneal inflammation induced by LPS and reduced the TGF-beta 1 expression in the peritoneal membranes.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 50 条
  • [31] Laparotomy Attenuates Lipopolysaccharide-Induced Gastric Bleeding in the Rat
    Ward, Jeremy L.
    Delano, Benjamin A.
    Adams, Sasha D.
    Mercer, Elizabeth E.
    Mercer, David W.
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (04) : 902 - 910
  • [32] Effect of early fluid resuscitation on the lung in a rat model of lipopolysaccharide-induced septic shock
    Liu, W.
    Shan, L. P.
    Dong, X. S.
    Liu, X. W.
    Ma, T.
    Liu, Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (02) : 161 - 169
  • [33] Protective Effect of Dihydromyricetin Against Lipopolysaccharide-Induced Acute Kidney Injury in a Rat Model
    Wang, Jun-Tao
    Jiao, Peng
    Zhou, Yun
    Liu, Qian
    MEDICAL SCIENCE MONITOR, 2016, 22 : 454 - 459
  • [34] Rosiglitazone suppresses lipopolysaccharide-induced matrix metalloproteinase-2 activity in rat aortic endothelial cells via Ras-MEK1/2 signaling
    Wu, Xianghong
    Li, Lang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (01) : 54 - 58
  • [35] Microparticles Mediate Lipopolysaccharide-induced Inflammation and Chronic Pain in Mouse Model
    Singh, Anjali
    Khushi, Vinod
    Tiwari, Vinod
    Kumar, Alok
    NEUROMOLECULAR MEDICINE, 2024, 26 (01)
  • [36] Complement terminal pathway inhibition reduces peritoneal injuries in a rat peritonitis model
    Kamegai, Naoki
    Kim, Hangsoo
    Suzuki, Yasuhiro
    Fukui, Sosuke
    Kojima, Hiroshi
    Maruyama, Shoichi
    Morgan, B. Paul
    Zelek, Wioleta Milena
    Mizuno, Masashi
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2023, 214 (02) : 209 - 218
  • [37] THE ROLE OF MONITORING GENTAMICIN LEVELS IN PATIENTS WITH GRAM-NEGATIVE PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS
    Tang, Wen
    Cho, Yeoungjee
    Hawley, Carmel M.
    Badve, Sunil V.
    Johnson, David W.
    PERITONEAL DIALYSIS INTERNATIONAL, 2014, 34 (02): : 219 - 226
  • [38] Eryptosis in Peritoneal Dialysis-Related Peritonitis: The Potential Role of Inflammation in Mediating the Increase in Eryptosis in PD
    Virzi, Grazia Maria
    Manani, Sabrina Milan
    Marturano, Davide
    Clementi, Anna
    Lerco, Silvia
    Tantillo, Ilaria
    Giuliani, Anna
    Battaglia, Giovanni Giorgio
    Ronco, Claudio
    Zanella, Monica
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [39] Inhibition of Rho-kinase alleviates peritoneal fibrosis and angiogenesis in a rat model of peritoneal dialysis
    Peng, Weisheng
    Zhou, Qiaoling
    Ao, Xiang
    Tang, Rong
    Xiao, Zhou
    RENAL FAILURE, 2013, 35 (07) : 958 - 966
  • [40] Effect of peritoneal dialysis fluid measured in vivo in a rat-model of continuous peritoneal dialysis
    Hekking, LHP
    Aalders, MC
    Van Gelderop, E
    Zweers, MM
    Struijk, DG
    Havenith, CEG
    Beelen, RHJ
    ADVANCES IN PERITONEAL DIALYSIS/1998, VOL 14, 1998, 14 : 14 - 18